JP2862175B2 - 細胞障害剤が有する神経障害作用の軽減のための医薬組成物 - Google Patents

細胞障害剤が有する神経障害作用の軽減のための医薬組成物

Info

Publication number
JP2862175B2
JP2862175B2 JP1028798A JP2879889A JP2862175B2 JP 2862175 B2 JP2862175 B2 JP 2862175B2 JP 1028798 A JP1028798 A JP 1028798A JP 2879889 A JP2879889 A JP 2879889A JP 2862175 B2 JP2862175 B2 JP 2862175B2
Authority
JP
Japan
Prior art keywords
composition
drug
collagen
composition according
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP1028798A
Other languages
English (en)
Japanese (ja)
Other versions
JPH021406A (ja
Inventor
イー．ラック エドワード
エム． ブラウン デニス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATORIKUSU PHARM Inc
Original Assignee
MATORIKUSU PHARM Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MATORIKUSU PHARM Inc filed Critical MATORIKUSU PHARM Inc
Publication of JPH021406A publication Critical patent/JPH021406A/ja
Application granted granted Critical
Publication of JP2862175B2 publication Critical patent/JP2862175B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fertilizers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP1028798A 1988-02-11 1989-02-09 細胞障害剤が有する神経障害作用の軽減のための医薬組成物 Expired - Fee Related JP2862175B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15498488A 1988-02-11 1988-02-11
US154984 1993-11-19

Publications (2)

Publication Number Publication Date
JPH021406A JPH021406A (ja) 1990-01-05
JP2862175B2 true JP2862175B2 (ja) 1999-02-24

Family

ID=22553654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1028798A Expired - Fee Related JP2862175B2 (ja) 1988-02-11 1989-02-09 細胞障害剤が有する神経障害作用の軽減のための医薬組成物

Country Status (7)

Country Link
EP (1) EP0328389B1 (fr)
JP (1) JP2862175B2 (fr)
AT (1) ATE77754T1 (fr)
CA (1) CA1330422C (fr)
DE (1) DE68901931T2 (fr)
ES (1) ES2045404T3 (fr)
GR (1) GR3005841T3 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5750146A (en) * 1995-04-28 1998-05-12 Matrix Pharmaceutical, Inc. Translucent collagen formulations with a cytotoxic drug
DE10037983B4 (de) * 2000-08-03 2006-04-13 Stefan Zikeli Polymerzusammensetzung und daraus hergestellter Formkörper mit einem Gehalt an Alkaloid
JP2003119156A (ja) * 2001-08-06 2003-04-23 Kikuji Yamashita コラーゲンを含有する口腔用剤、医薬品および医薬部外品
CN1923281B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含植物生物碱的抗癌缓释注射剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179753B (en) * 1977-10-13 1982-12-28 Richter Gedeon Vegyeszet Process for producting synergetic pharmaceutical compositions of citostatic activity
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas

Also Published As

Publication number Publication date
GR3005841T3 (fr) 1993-06-07
EP0328389B1 (fr) 1992-07-01
EP0328389A2 (fr) 1989-08-16
ES2045404T3 (es) 1994-01-16
ATE77754T1 (de) 1992-07-15
DE68901931D1 (de) 1992-08-06
EP0328389A3 (en) 1989-10-11
CA1330422C (fr) 1994-06-28
DE68901931T2 (de) 1992-12-10
JPH021406A (ja) 1990-01-05

Similar Documents

Publication Publication Date Title
US4619913A (en) Treatments employing drug-containing matrices for introduction into cellular lesion areas
JP2750138B2 (ja) 細胞毒性薬との組合せにおける血管収縮性物質
KR20060002922A (ko) 비수성 단일 상 비히클 및 이러한 비히클을 이용한 제형
AU2009200125B2 (en) Controlled release polymeric compositions of bone growth promoting compounds
JPH05500225A (ja) 細胞増殖を抑制するためのＴＧＦ―βタンパク質組成物
KR20000069564A (ko) 겔 조성물 및 방법
EP0140255A2 (fr) Injections à libération prolongée
USRE35748E (en) Treatments employing drug containing matrices for introduction into cellular lesion areas
JP2009506101A (ja) アナストロゾールを含む延長放出製剤
JPH11514650A (ja) 治療用シスプラチン（ｃｄｄｐ）のための改良された方法及び組成物
JP2862175B2 (ja) 細胞障害剤が有する神経障害作用の軽減のための医薬組成物
US20100035952A1 (en) Radiosensitizer Formulations and Methods for Use
JP2005538052A (ja) 注射製剤
Okumu et al. Implants and injectables
JPH0678241B2 (ja) ｔＰＡ医薬組成物
WO2003041645A2 (fr) Methode de vaccination d'un patient humain pour prevenir les tumeurs metastatiques
SINGH et al. COMPARATIVE BIO-AVAILABILITY, PHARMACOKINETICS AND DOSAGE REGIMEN OF THREE DIFFENTS BRANDS OF OXYTETRACYCLINE IN DAIRY COWS AFTER INTRAMUSCULAR ADMINISTRATION

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees